{
    "info": {
        "nct_id": "NCT05702749",
        "official_title": "Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients with Vestibular Schwannomas",
        "inclusion_criteria": "1. Provision of signed and dated informed consent form\n2. Male or female participants ≥18 years of age.\n3. Initial diagnosis of a Vestibular Schwannoma confirmed by a physician with an internal auditory canal (IAC) MRI, in accordance with standard or institutional practice\n4. VS patients who present with a tumor size ≤2.5 cm and will be treated with surgery or SRS\n5. Eastern Cooperative Oncology Group (ECOG) Performance Status <2\n6. Within 14 days of study registration, participants must have normal laboratory values that support safe treatment, at the discretion of the treating investigator\n7. Be willing to adhere to outlined study protocol criteria and complete self-reported questionnaires (translations may be made available if the patient' primary language is not English).\n8. For females of reproductive potential: must have a negative urine or serum pregnancy test 7 prior to enrollment and agreement to use of highly effective contraception method during study participation and for an additional 24 weeks after the completion of stereotactic radiosurgery.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Subjects less than 18 years of age\n2. Prior treatment of VS including radiotherapy or surgery or treatment for disease recurrence or planned salvage procedure\n3. Pre-existing, secondary vestibular diagnoses (e.g., Meniere's, intractable benign paroxysmal positional vertigo (BPPV), vestibular migraine, 3PD).\n4. Other medical comorbidities know to significantly impair/affect balance and/or vestibular function testing (e.g., prior stroke, uncorrected visual impairment or blindness, etc.)\n5. Anticipated radiation other than stereotactic (fractionated)\n6. Inability to undergo MRI scans safely\n7. Allergy to Gadolinium contrast used for MRI scans\n8. Women of childbearing potential who are known to be pregnant or are unwilling to use an acceptable method of contraception from the time of informed consent until completion of study related treatment and additional 24 weeks following stereotactic radiosurgery administration.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Provision of signed and dated informed consent form",
            "criterions": [
                {
                    "exact_snippets": "Provision of signed and dated informed consent form",
                    "criterion": "informed consent form",
                    "requirements": [
                        {
                            "requirement_type": "signed",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "dated",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "provision",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. VS patients who present with a tumor size ≤2.5 cm and will be treated with surgery or SRS",
            "criterions": [
                {
                    "exact_snippets": "tumor size ≤2.5 cm",
                    "criterion": "tumor size",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "cm"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "will be treated with surgery or SRS",
                    "criterion": "treatment modality",
                    "requirements": [
                        {
                            "requirement_type": "planned treatment",
                            "expected_value": [
                                "surgery",
                                "SRS"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Initial diagnosis of a Vestibular Schwannoma confirmed by a physician with an internal auditory canal (IAC) MRI, in accordance with standard or institutional practice",
            "criterions": [
                {
                    "exact_snippets": "Initial diagnosis of a Vestibular Schwannoma",
                    "criterion": "Vestibular Schwannoma",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_status",
                            "expected_value": "initial diagnosis"
                        }
                    ]
                },
                {
                    "exact_snippets": "confirmed by a physician",
                    "criterion": "Vestibular Schwannoma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "confirmation_by_physician",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "with an internal auditory canal (IAC) MRI",
                    "criterion": "Vestibular Schwannoma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "confirmation_method",
                            "expected_value": "internal auditory canal (IAC) MRI"
                        }
                    ]
                },
                {
                    "exact_snippets": "in accordance with standard or institutional practice",
                    "criterion": "diagnostic procedure",
                    "requirements": [
                        {
                            "requirement_type": "procedure_standard",
                            "expected_value": [
                                "standard practice",
                                "institutional practice"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Male or female participants ≥18 years of age.",
            "criterions": [
                {
                    "exact_snippets": "Male or female participants",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "male",
                                "female"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "≥18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Within 14 days of study registration, participants must have normal laboratory values that support safe treatment, at the discretion of the treating investigator",
            "criterions": [
                {
                    "exact_snippets": "Within 14 days of study registration, participants must have normal laboratory values that support safe treatment, at the discretion of the treating investigator",
                    "criterion": "laboratory values",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": "within 14 days of study registration"
                        },
                        {
                            "requirement_type": "normality",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "suitability for safe treatment",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "investigator discretion",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Eastern Cooperative Oncology Group (ECOG) Performance Status <2",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) Performance Status <2",
                    "criterion": "ECOG Performance Status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Be willing to adhere to outlined study protocol criteria and complete self-reported questionnaires (translations may be made available if the patient' primary language is not English).",
            "criterions": [
                {
                    "exact_snippets": "Be willing to adhere to outlined study protocol criteria",
                    "criterion": "adherence to study protocol",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "complete self-reported questionnaires",
                    "criterion": "completion of self-reported questionnaires",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. For females of reproductive potential: must have a negative urine or serum pregnancy test 7 prior to enrollment and agreement to use of highly effective contraception method during study participation and for an additional 24 weeks after the completion of stereotactic radiosurgery.",
            "criterions": [
                {
                    "exact_snippets": "females of reproductive potential",
                    "criterion": "sex and reproductive potential",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "reproductive potential",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must have a negative urine or serum pregnancy test 7 prior to enrollment",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "test type",
                            "expected_value": [
                                "urine pregnancy test",
                                "serum pregnancy test"
                            ]
                        },
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to enrollment"
                        }
                    ]
                },
                {
                    "exact_snippets": "agreement to use of highly effective contraception method during study participation and for an additional 24 weeks after the completion of stereotactic radiosurgery",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "contraception method effectiveness",
                            "expected_value": "highly effective"
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "during study participation and for an additional 24 weeks after the completion of stereotactic radiosurgery"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "2. Prior treatment of VS including radiotherapy or surgery or treatment for disease recurrence or planned salvage procedure",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment of VS including radiotherapy or surgery",
                    "criterion": "prior treatment of vestibular schwannoma (VS)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "treatment for disease recurrence",
                    "criterion": "treatment for disease recurrence",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "planned salvage procedure",
                    "criterion": "planned salvage procedure",
                    "requirements": [
                        {
                            "requirement_type": "planned",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Allergy to Gadolinium contrast used for MRI scans",
            "criterions": [
                {
                    "exact_snippets": "Allergy to Gadolinium contrast used for MRI scans",
                    "criterion": "allergy to Gadolinium contrast",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Pre-existing, secondary vestibular diagnoses (e.g., Meniere's, intractable benign paroxysmal positional vertigo (BPPV), vestibular migraine, 3PD).",
            "criterions": [
                {
                    "exact_snippets": "Pre-existing, secondary vestibular diagnoses (e.g., Meniere's, intractable benign paroxysmal positional vertigo (BPPV), vestibular migraine, 3PD)",
                    "criterion": "secondary vestibular diagnoses",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "pre-existing",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Anticipated radiation other than stereotactic (fractionated)",
            "criterions": [
                {
                    "exact_snippets": "Anticipated radiation other than stereotactic (fractionated)",
                    "criterion": "anticipated radiation",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": "other than stereotactic (fractionated)"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Subjects less than 18 years of age",
            "criterions": [
                {
                    "exact_snippets": "less than 18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Women of childbearing potential who are known to be pregnant or are unwilling to use an acceptable method of contraception from the time of informed consent until completion of study related treatment and additional 24 weeks following stereotactic radiosurgery administration.",
            "criterions": [
                {
                    "exact_snippets": "Women of childbearing potential who are known to be pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnancy",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Women of childbearing potential who ... are unwilling to use an acceptable method of contraception from the time of informed consent until completion of study related treatment and additional 24 weeks following stereotactic radiosurgery administration",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "willingness to use contraception",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "contraception duration",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "from informed consent until completion of study related treatment and additional 24 weeks following stereotactic radiosurgery administration"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Inability to undergo MRI scans safely",
            "criterions": [
                {
                    "exact_snippets": "Inability to undergo MRI scans safely",
                    "criterion": "ability to undergo MRI scans safely",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Other medical comorbidities know to significantly impair/affect balance and/or vestibular function testing (e.g., prior stroke, uncorrected visual impairment or blindness, etc.)",
            "criterions": [
                {
                    "exact_snippets": "Other medical comorbidities know to significantly impair/affect balance and/or vestibular function testing",
                    "criterion": "medical comorbidities affecting balance or vestibular function",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "prior stroke",
                    "criterion": "prior stroke",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "uncorrected visual impairment or blindness",
                    "criterion": "uncorrected visual impairment or blindness",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}